Lindane Bioassay Studies and Human Cancer Risk Assessment

Abstract

Benzene hexachloride or hexachtorocyclohexane comes in eight isomeric forms which differ in the spatial positions of the chlorine atoms on the boat and chair forms. Only one, however, γ-isomer (lindane) possesses relevant insecticidal activity. The majority of studies on the potential carcinogenicity of benzene hexachloride, however, did not discriminate between the various isomers because they assumed that carcinogenicity is independent of steric structure. Also, proper differentiation between morphologic endpoints was not duly carried out and considered.

The present evaluation of lindane's biologic activity was restricted to the lifelong studies in which pure lindane (>99.5%) was utilized and the morphology of the observed lesions, mainly in the liver, were classified according to their biologic behavior into hyperplastic, benign neoplastic, and malignant entities. None of the studies gave evidence that lindane was carcinogenic in mice and rats. An enhancement of benign liver tumors (tumorigenic effect) was observed only in CF₁ male mice (17/56 at the only tested dose: 400 ppm vs. 3/89 observed in the nontreated controls). Dose-response function of this tumor response in conjunction with two other lifetime studies (80 and 160 ppm in B6C3F₁ and 50, 25, and 12.5 ppm in NMRI mice) were best described by the Weibull model, giving a relatively high estimate of its shape parameter (m = 2.5). Assuming similar susceptibility of humans to lindane and considering maximal occupational exposure to this agent (professional applicators), the probability of lindane associated tumor development was estimated as 2.2times10^-10. Because this cancer risk is five orders of magnitude below the acceptable health risk, this evaluation concludes that environmental exposure to lindane does not pose a threat to human health.

References

1. Herbst M , Weisse I , Koellmer H : A contribution to the question of the possible hepatocarcinogenic effects of lindane. Toxicol 4: 91–96, 1975.

2. Thorpe E , Walker AIT : The toxicology of dieldrin (HEOD). II. Comparative long-term oral toxicity studies in mice with dieldrin, DDT, phenobarbitone, beta-BHC and gamma-BHC. Food Cosmet Toxicol 11 (3):433–442, 1973.

3. Weisse I , Herbst M : Carcinogenicity study of lindane in the mouse. Toxicol 7: 233–238, 1977.

4. National Cancer Institute, U. S. Department of Health, Education and Welfare, Public Health Service: Bioassay of lindane for possible carcinogenicity. CAS No. 58-89-9 Technical Report Series NCI-CC-TR-14. DHEW Publication No. (NIH) 77-814, 1977.

5. Ito N , Nagasaki H , Arai M : Interactions of liver tumorigenesis in mice treated with technical poly-chlorinated biphenyls (PCBs) and benzene hexachloride (BHC) in New Methods in Environmental Chemistry and Ecological Chemistry. F Coulston , F Korte , M Goto , editors. International Academic Printing Co., Tokyo, 1973, pp. 141–147.

6. Nagasaki H , Tomii S , Mega T , Marugami M , Ito N : Hepatocarcinogenic effect of alpha-, beta-, gamma-, and delta-isomers of benzene hexachloride in mice. Gann 63 (3):393, 1972.

7. Nagasaki H , Tomii S , Meta T , Marugami M , Ito N : Carcinogenicity of benzene hexachloride (BHC) in Topics in Chemical Carcinogenesis. W Nakahara , S Takayama , T Sugimura , S Odashima , editors. University of Tokyo Press, Tokyo, 1972, pp. 343–353.

8. Schulte-Hermann, R , Parzefall W : Failure to discriminate initiation from promotion of liver tumors in a long-term study with the phenobarbital type inducer α-hexachlorocyclohexane and the role of sustained stimulation of hepatic growth and mono-oxygenases. Cancer Res 41: 4140–4146, 1981.

9. Vesselinovitch SD , Mihailovich N , Rao, KVN : Morphology and metastatic nature of induced hepatic nodular lesions in C57BLxC3H F1 mice. Cancer Res 38: 2003–2010, 1978.

10.

10. Vesselinovitch SD , Mihailovich N : Kinetics of induction and growth of basophilic foci and development of hepatocellular carcinoma by diethylnitrosamine in the infant mouse in Current Perspectives in Mouse Liver Neoplasia. Symposium of the Fourth Annual CUT Conference on Toxicology, Raleigh, North Carolina, December 3-4, 1981.

11.

11. Kyriazis AP , Vesselinovitch SD : Transplantability and biological behavior of mouse liver tumors induced by ethylnitrosourea. Cancer Res 33: 332–338, 1973.

12.

12. Vesselinovitch SD : Liver tumor induction. Toxicol Path 10, No. 2, 1983.

13.

13. Goto M , Hattori M , Miyagawa T , Enomoto M : Contribution of ecological chemistry. II. Hepatoma formation in mice after administration of HCH isomers in high doses (Germ.). Chemosphere 6: 279–282, 1972.

14.

14. Hanada M , Yatani C , Miyaji T : Induction of hepatoma in mice by benzene hexachloride. Gann 64: 511–513, 1973.

15.

15. Ito N , Nagasaki H , Aoe H , Sugihara S , Miyata Y , Arai M , Shirai T : Development of hepatocellular carcinomas in rats treated with benzene hexachloride. J Natl Cancer inst 54: 801–805, 1975.

16.

16. Fitzhugh OG , Nelson AA , Frawley JP : The chronic toxicities of technical benzene hexachloride and its alpha, beta and gamma isomers. J Pharmacol Exp Ther 100: 59–66, 1950.

17.

17. Carlborg FW : Dose-response functions in carcinogenesis and the Weibull model. Foot Cosmet Toxicol 19: 225–263, 1981.

18.

18. Carlborg FW : Multi-stage dose-response models in carcinogenesis. Food Cosmet Toxicol 19: 361–365, 1981.

19.

19. Carlborg FW : 2-AAF and the Weibull model. Food Cosmet Toxicol 19: 367–371, 1981.

20.

20. Staffa JA , Mehlman MA : Innovations in Cancer Risk Assessment. Pathotox Publishers, Inc., Park Forest South, Illinois, 1979.

21.

21. Graham SL , Davis KJ , Hansen WH , Graham CH : Effects of prolonged ethylene thiourea ingestion on the thyroid of the rat. Food Cosme. Toxicol 13: 493, 1975.

22.

22. Harvey RG : Activated metabolites of carcinogenic hydrocarbons. Acc Chem Res 14: 218–226, 1981.

23.

23. Osborne MR , Jacobs S , Harvey RG , Brookes P : Minor products from the reaction of (+) and (-) benzo(a)pyrene-antidiolepoxide with DNA. Carcinogenesis 2: 553–558, 1981.